295 related articles for article (PubMed ID: 26970080)
1. Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia?
Stephens GJ
J Physiol; 2016 Aug; 594(16):4631-41. PubMed ID: 26970080
[TBL] [Abstract][Full Text] [Related]
2. The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signalling.
Wang X; Whalley BJ; Stephens GJ
J Physiol; 2013 Aug; 591(16):3919-33. PubMed ID: 23732642
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model.
Ranjbar H; Soti M; Janahmadi M; Kohlmeier KA; Sheibani V; Ahmadi-Zeidabadi M; Shabani M
Exp Brain Res; 2022 Sep; 240(9):2339-2348. PubMed ID: 35859208
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.
Rodríguez-Cueto C; Hernández-Gálvez M; Hillard CJ; Maciel P; García-García L; Valdeolivas S; Pozo MA; Ramos JA; Gómez-Ruiz M; Fernández-Ruiz J
Neuroscience; 2016 Dec; 339():191-209. PubMed ID: 27717809
[TBL] [Abstract][Full Text] [Related]
5. Components of Endocannabinoid Signaling System Are Expressed in the Perinatal Mouse Cerebellum and Required for Its Normal Development.
Martinez LR; Black KC; Webb BT; Bell A; Baygani SK; Mier TJ; Dominguez L; Mackie K; Kalinovsky A
eNeuro; 2020; 7(2):. PubMed ID: 32179579
[TBL] [Abstract][Full Text] [Related]
6. The cannabinoid system and immune modulation.
Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid antagonist, AM251 attenuates ataxia related deficiencies in a cerebellar ataxic model.
Ranjbar H; Soti M; Kohlmeier KA; Sheibani V; Ahmadi-Zeidabadi M; Rafiepour K; Shabani M
Int J Neurosci; 2024 May; 134(5):522-529. PubMed ID: 36120979
[No Abstract] [Full Text] [Related]
8. Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.
Gómez-Ruiz M; Rodríguez-Cueto C; Luna-Piñel E; Hernández-Gálvez M; Fernández-Ruiz J
Front Mol Neurosci; 2019; 12():94. PubMed ID: 31068788
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress.
Hill MN; Patel S; Carrier EJ; Rademacher DJ; Ormerod BK; Hillard CJ; Gorzalka BB
Neuropsychopharmacology; 2005 Mar; 30(3):508-15. PubMed ID: 15525997
[TBL] [Abstract][Full Text] [Related]
10. The neurobiology and evolution of cannabinoid signalling.
Elphick MR; Egertová M
Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
12. Role of the Endocannabinoidome in Human and Mouse Atherosclerosis.
Piscitelli F; Silvestri C
Curr Pharm Des; 2019; 25(29):3147-3164. PubMed ID: 31448709
[TBL] [Abstract][Full Text] [Related]
13. The role of CB1 receptors in psychostimulant addiction.
Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
Mackie K
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S19-23. PubMed ID: 16570100
[TBL] [Abstract][Full Text] [Related]
15. Ion channel dysfunction in cerebellar ataxia.
Bushart DD; Shakkottai VG
Neurosci Lett; 2019 Jan; 688():41-48. PubMed ID: 29421541
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system and the neuroendocrine control of hydromineral balance.
Ruginsk SG; Vechiato FM; Elias LL; Antunes-Rodrigues J
J Neuroendocrinol; 2014 Jun; 26(6):370-6. PubMed ID: 24750469
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias.
Rodríguez-Cueto C; Benito C; Romero J; Hernández-Gálvez M; Gómez-Ruiz M; Fernández-Ruiz J
Pathobiology; 2014; 81(3):149-59. PubMed ID: 24642775
[TBL] [Abstract][Full Text] [Related]
18. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid signalling in stem cells and cerebral organoids drives differentiation to deep layer projection neurons via CB
Paraíso-Luna J; Aguareles J; Martín R; Ayo-Martín AC; Simón-Sánchez S; García-Rincón D; Costas-Insua C; García-Taboada E; de Salas-Quiroga A; Díaz-Alonso J; Liste I; Sánchez-Prieto J; Cappello S; Guzmán M; Galve-Roperh I
Development; 2020 Dec; 147(24):. PubMed ID: 33168583
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of cannabinoids.
Grotenhermen F
Neuro Endocrinol Lett; 2004; 25(1-2):14-23. PubMed ID: 15159677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
